India halts production of syrup linked to Gambia deaths
Medications contained intolerable levels of chemicals that can harm the kidneys.
Boakyewaa Lawrencia 
Following news that cough syrups may have contributed to the deaths of dozens of children in The Gambia, Indian authorities ordered a pharmaceutical company to stop manufacturing its products.
Anil Vij, the health minister for the state of Haryana, reported that checks at a Maiden Pharmaceuticals business turned up numerous instances of improper procedures.
The World Health Organization stated last week that the company's medications contained intolerable levels of chemicals that can harm the kidneys.
The deaths of 66 children, which have been linked to four brands of cough syrup imported from India, are being looked into, according to authorities in The Gambia.
Last week, Maiden Pharmaceuticals expressed astonishment and sadness over the tragedy and said they were assisting with the investigation.
